Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
A 47-year-old male, born in India, with genotype 3a chronic hepatitis C virus infection, a responder-relapser to 24 weeks of pegylated interferon and ribavirin therapy, successfully underwent elective liver transplantation (LT) for hepatocellular carcinoma (two lesions; 30 mm, Segment VIII, and 26 mm, Segment V) and synthetic dysfunction (MELD 8). He received a heart beating donor graft; his immunosuppression regimen consisted of tacrolimus and a …
Competing interests None.
Patient consent Obtained.
Ethics approval The data presented in this manuscript are not part of a research study and do not need ethical approval.
Provenance and peer review Not commissioned; internally peer reviewed.